Sun Pharma posts Q3FY18 results
Q3 adjusted net profit was at Rs 878 crores Sun Pharmaceutical Industries has posted third quarter and nine month financial…
Author
ACG appoints Steven Facer as Vice President – Europe
Facer will be responsible for supporting ambitious growth plans for the company's capsules business across the region ACG has…
Strand Life Sciences closes financing led by Quadria Capital
The investment will be utilised to fund the growth and expansion of Strand towards becoming Asia’s leading integrated diagnostics…
DRL recalls 80,000+ bottles of Atorvastatin from US
The product was manufactured at the drug maker’s Srikakulam plant in Andhra Pradesh Dr Reddy’s Laboratories (DRL) has initiated…
Novartis India appoints Jawed Zia as VC and MD
His appointment is effective March 1, 2018 At a meeting held in Mumbai today, the Board of Directors of Novartis India announced…
Mylan, Biocon receive CHMP opinion for Semglee, biosimilar insulin glargine
Marketing applications for Semglee have been submitted in Australia, Canada, and the US and are planned for key emerging markets…
Lupin launches Flucytosine capsules in US market
The product is the generic version of Valeant Pharmaceuticals International's Ancobon tablets Lupin has launched Flucytosine…
Pharma sector earnings to remain muted in Dec quarter: Edelweiss Securities
The report, however, noted that domestic sales are expected to grow 12 per cent year-on-year on a low base Pharma sector’s…
CCI slaps fine on two Gujarat chemists associations
The two associations are Chemists and Druggists Association of Baroda (CDAB) and Federation of Gujarat State Chemists &…
Sun Pharma announces US FDA acceptance of NDA for OTX-101
OTX-101 is being evaluated for treatment of dry eye disease Sun Pharma has announced that the US FDA has accepted a New Drug…